Benjamin Ellingson, a professor of radiology and psychiatry in the David Geffen School of Medicine at UCLA and member of the UCLA Jonsson Comprehensive Cancer Center, has received a Defense Department Idea grant to develop a new non-invasive imaging method for quantifying metabolic activity within brain tumors.
Early endpoints have the potential to get effective drugs to patients faster, but granting approval to drugs—even accelerated approval—comes with the risk that ineffective or even harmful drugs will be given to patients.
